PACAP inhibits high fat-induced NLRP3 inflammasome-mediated pyroptosis in vascular endothelial cells by regulating the SIRT1/ROS pathway
Molecular and Cellular Endocrinology · 2025
DOI: 10.1016/j.mce.2025.112633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Jixiang Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine, Department of Cellular Biology, Jinan University, Guangzhou, 510632, China; National Engineering Research Center of Genetic…. Hauptthemen laut MEDLINE: Diet, High-Fat, Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein, Pituitary Adenylate Cyclase-Activating Polypeptide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
High-fat diet (HFD)-induced obesity leads endothelial dysfunction and contributes to cardiovascular diseases. NLRP3-mediated pyroptosis plays a key role in endothelial injury induced by HFD. Pituitary adenylate cyclase activating polypeptide (PACAP), a neuropeptide belonging to the secretin family, has demonstrated diverse beneficial effects. However, its impact on a high-fat-induced pyroptosis remains unexplored. The purpose of this study is to evaluate the effect of PACAP in alleviating high-fat-induced pyroptosis of human umbilical vein endothelial cells (HUVECs) and to elucidate its potential mechanisms. The results show that palmitic acid (PA) induces HUVECs injury and pyroptosis, while PACAP alleviates PA-induced HUVECs injury and pyroptosis. In addition, PACAP also has a protective effect on vascular damage in the thoracic aorta of obese mice. We further found that PACAP reduced PA-induced intracellular Reactive Oxygen Species (ROS) in HUVECs, while also mitigating PA-induced HUVECs pyroptosis. Moreover, PACAP can inhibit PA-induced ROS and pyroptosis through activation of SIRT1, and the effects of PACAP are reversed by a SIRT1 inhibitor. In conclusion, our study demonstrates that PACAP can inhibit PA-induced oxidative stress and pyroptosis in HUVECs, and its action is closely related to the SIRT1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedicine, Department of Cellular Biology, Jinan University, Guangzhou, 510632, China; National Engineering Research Center of Genetic Medicine, Key Laboratory of Bioengineering Medicine of Guangdong Prov…
- School of Medicine, Jinan University, Guangzhou, 510632, China.
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Dong, J., Ma, T., Qu, Y., Ye, R., Feng, J., Bai, G., Hong, A., & Ma, Y. (2025). PACAP inhibits high fat-induced NLRP3 inflammasome-mediated pyroptosis in vascular endothelial cells by regulating the SIRT1/ROS pathway. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2025.112633
Vancouver
Dong J, Ma T, Qu Y, Ye R, Feng J, Bai G, et al. PACAP inhibits high fat-induced NLRP3 inflammasome-mediated pyroptosis in vascular endothelial cells by regulating the SIRT1/ROS pathway. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2025.112633
BibTeX
@article{Dong2025,
author = {Dong, Jixiang and Ma, Tianyu and Qu, Yichen and Ye, Runquan and Feng, Jia and Bai, Ge and Hong, An and Ma, Yi},
title = {PACAP inhibits high fat-induced NLRP3 inflammasome-mediated pyroptosis in vascular endothelial cells by regulating the SIRT1/ROS pathway},
journal = {Molecular and Cellular Endocrinology},
year = {2025},
doi = {10.1016/j.mce.2025.112633}
}
EUVIMED